Family Planning Associates Medical Group INC
Family Planning Associates Medical Group INC was paid $10.35M by Medicaid between Jan 2018 and Dec 2024, across 55 billing codes. Its largest line is S0199, Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs — 19% of everything it billed.
LONG BEACH, CA 90806
Next to other Clinical Medical Laboratory providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,245 | $272K | |
| 2019 | 24,175 | $864K | |
| 2020 | 37,823 | $1.44M | |
| 2021 | 58,875 | $2.10M | |
| 2022 | 62,539 | $2.39M | |
| 2023 | 69,019 | $1.90M | |
| 2024incomplete | 78,791 | $1.39M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 19% | 5,411 | 5,264 | $1.95M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 12% | 37,692 | 37,172 | $1.22M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 11% | 37,646 | 37,145 | $1.14M |
| 87806 | 6.5% | 38,563 | 37,064 | $677K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.9% | 27,224 | 26,163 | $611K |
| 59840 | 4.8% | 2,950 | 1,611 | $501K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 3.3% | 581 | 581 | $346K |
| 58300 | 3.3% | 3,473 | 1,818 | $336K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2.9% | 3,691 | 3,484 | $305K |
| A4267 | Contraceptive supply, condom, male, each | 2.7% | 14,501 | 14,414 | $276K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2.5% | 14,562 | 14,442 | $261K |
| J3490 | Unclassified drugs | 2.4% | 11,432 | 10,778 | $253K |
43 more codes
| 87799 | 2.2% | 9,913 | $223K | |
| 87481 | 2.0% | 9,924 | $203K | |
| 11981 | 1.9% | 1,153 | $198K | |
| 90651 | 1.8% | 1,072 | $187K | |
| S0190 | Mifepristone, oral, 200 mg | 1.7% | 3,082 | $179K |
| 81025 | 1.6% | 67,349 | $169K | |
| 99213 | Doctor's office visit, returning patient (routine) | 1.5% | 5,094 | $154K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 1.3% | 207 | $135K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 1.3% | 4,028 | $130K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.1% | 1,397 | $111K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.1% | 3,120 | $110K |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 3,742 | $99K |
| 58301 | <1% | 2,276 | $95K | |
| G9920 | Screening performed and negative | <1% | 3,148 | $79K |
| 87563 | <1% | 3,680 | $66K | |
| 99000 | <1% | 6,135 | $61K | |
| 76830 | Ultrasound, transvaginal | <1% | 887 | $42K |
| 11976 | <1% | 951 | $42K | |
| 90649 | <1% | 219 | $33K | |
| 88142 | <1% | 1,798 | $27K | |
| S4993 | Contraceptive pills for birth control | <1% | 1,147 | $21K |
| 85018 | <1% | 4,107 | $18K | |
| J7296 | Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg | <1% | 26 | $15K |
| 01966 | <1% | 1,686 | $12K | |
| 86592 | <1% | 2,656 | $9K | |
| 81002 | <1% | 3,825 | $7K | |
| T1014 | Telehealth transmission, per minute, professional services bill separately | <1% | 1,422 | $6K |
| 86901 | <1% | 2,167 | $6K | |
| 11982 | <1% | 119 | $5K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 105 | $5K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 74 | $5K |
| 59841 | <1% | 19 | $4K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 373 | $3K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 173 | $3K |
| 99201 | <1% | 96 | $3K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 250 | $2K |
| 86703 | <1% | 117 | $1K | |
| 87529 | <1% | 85 | $1K | |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 40 | $615.68 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 27 | $406.35 |
| 99152 | <1% | 12 | $278.96 | |
| A4268 | Contraceptive supply, condom, female, each | <1% | 28 | $146.81 |
| A4649 | Surgical supply; miscellaneous | <1% | 12 | $43.75 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.